Table 2.
List of trials current in the i-CIP network and trials that have agreed to share data (total n=17 526 individuals)
| Author, year | Country | Study population risk of PE/start of intervention | Intervention | Comparator | Sample size | Data already shared with the i-CIP network |
| Trials currently in iCIP (n=16 111 individuals, 7 trials) (data available already) | ||||||
| Villar,49 2006 | Argentina, Egypt, India, Peru, South Africa, Vietnam | High risk, up to 20 weeks’ gestation | 1500 mg calcium carbonate | Placebo | 8325 | Yes |
| Levine,50 1997 | USA | Low risk, 13–21 weeks’ gestation | 2000 mg calcium carbonate | Placebo | 4589 | Yes |
| Belizán,51 1991 | Argentina | Any risk, 20 weeks’ gestation | 2000 mg calcium carbonate | Placebo | 1194 | Yes |
| Ettinger,52 2009 | Mexico | Low risk, first trimester | 1200 mg calcium carbonate | Placebo | 670 | Yes |
| Goldberg,53 2013 | Gambia | Any risk, 18–20 weeks’ gestation | 1500 mg calcium carbonate | Placebo | 662 | Yes |
| Hofmeyr,54 2019 | Argentina, South Africa, Zimbabwe | High risk, prepregnancy and up to 20 weeks’ gestation | 500 mg calcium carbonate | Placebo | 581 | Yes |
| Azami,55 2017 | Iran | High risk, >20 weeks’ gestation | 800 mg calcium carbonate | Multivitamin | 90 | Yes |
| Trials that agreed to share IPD (n=1415 individuals, 7 trials) (data expected to be made available to us) | ||||||
| Omotayo,56 2018 | Kenya | Low risk, 16–30 gestational weeks | 1500 mg calcium carbonate | 1000 mg calcium carbonate | 990 | No |
| Asemi,57 2014 | Iran | Low risk, 16 weeks’ gestation | Multivitamin-mineral with 250 mg calcium | Multivitamin | 104 | No |
| Karamali,58 2016 | Iran | High risk, 24–26 weeks’ gestation | 1000 mg calcium carbonate, 50 000 IU vitamin D3 | Placebo | 60 | No |
| Samimi,59 2016 | Iran | High risk, 20 weeks’ gestation | 1000 mg calcium carbonate, 50 000 IU vitamin D3 | Placebo | 60 | No |
| Souza,60 2014 | Brazil | High risk, 20–27 weeks’ gestation | 2000 mg calcium carbonate, 100 mg aspirin | Placebo | 49 | No |
| Asemi,61 2015 | Iran | High risk, 27 weeks’ gestation | 800 mg calcium carbonate, 200 mg magnesium, 8 mg zinc, 400 IU vitamin D3 | Placebo | 46 | No |
| Asemi,62 2016 | Iran | Low risk, 25 weeks’ gestation | 500 mg calcium carbonate, 200 IU vitamin D3 | Placebo | 46 | No |
i-CIP, International Calcium in Pregnancy; PE, pre-eclampsia.